Display Single Record

FOI Request

Disclosure ID
FOI/03310
Request Date
September 9, 2019
Subject
Chronic Lymphocytic Leukaemia
Description

1). Does your trust treat adult multiple myeloma [MM] ? – if you refer your multiple myeloma patients to another centre, please state which.

2). If yes, then how many multiple myeloma patients, have been treated in the past 6 months with the following;

  • Bortezomib [Velcade]
  • Carfilzomib [Kyprolis]
  • Ixazomib [Ninlaro]
  • Lenalidomide [Revlimid]
  • Daratumumab [Darzalex]
  • Melphalan, prednisolone and thalidomide (known as MPT)
  • Cyclophosphamide, thalidomide and dexamethasone (known as CTD)

•   Pomalidomide [Imnovid]

3). Over the past 6 months [latest possible], how many chronic lymphocytic leukaemia (CLL) patients have you treated?

If possible, how many CLL patients treated were new to therapy in the past 3 months?

4). How many chronic lymphocytic leukaemia patients, have been treated in the past 6 months with the following;

  • Fludarabine (Fludara), cyclophosphamide (Cytoxan), and rituximab (known as FCR)
  • Bendamustine and rituximab (known as BR)
  • Ibrutinib [Imbruvica]
  • Chlorambucil
  • Venetoclax
  • Obinutuzumab
  • Idelalisib
  • Fludarabine and rituximab (known as FR)
  • High-dose prednisone and rituximab
  • Pentostatin (Nipent), cyclophosphamide, and rituximab (known as PCR)

•   Alemtuzumab (Campath) with rituximab

Response

1). I can confirm our Trust does treat adult multiple myeloma [MM]

2). We do not routinely record this information, to retrieve it would require a manual trawl of patient case notes which would exceed 18 hours. This information is therefore exempt on the grounds of cost (Section 12(1)).

3). We do not routinely record this information, to retrieve it would require a manual trawl of patient case notes which would exceed 18 hours. This information is therefore exempt on the grounds of cost (Section 12(1)).

4). We do not routinely record this information, to retrieve it would require a manual trawl of patient case notes which would exceed 18 hours. This information is therefore exempt on the grounds of cost (Section 12(1)).

Attachment 1
Attachment 2
Attachment 3
Attachment 4
Attachment 5
Attachment 6
Attachment 7
Attachment 8
Attachment 9